Reproductive Endocrinology And Infertility Clinical Training Program
Reproductive Endocrinology And Infertility Clinical Training Program
批准号:
8736973
负责人:
James H. Segars
金额:
$104.85万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AKAP13 geneAllelesAmericanCardiacCardiac MyocytesCell CommunicationCellsCharacteristicsClinicalClinical ResearchClinical TrialsDevelopmentDiseaseEstrogen ReceptorsEstrogensExtracellular MatrixFellowship ProgramFibroid TumorFrequenciesGene TargetingGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsInfertilityInfertility studyJournalsKnock-outMagnetic Resonance ImagingMechanicsMethodsMusNational Institute of Child Health and Human DevelopmentPhenotypePrevalenceProteinsReceptor ActivationReproductionReproductive EndocrinologyReproductive HealthReproductive MedicineResearchResearch PersonnelRoleSignal TransductionSocietiesStimulusSystemTraining ProgramsUltrasonographyUnited StatesUterine FibroidsWomanWood materialabstractingclinically relevantendometriosishealth disparityimmune functionin uteromeetingsmyocyte-specific enhancer-binding factor 2offspringprogramsreproductiveresponserhospecial interest groupsymposiumtumor
中文摘要
子宫肌瘤
到生育年龄结束时,美国超过50%的女性患上子宫肌瘤,使其成为女性最普遍的生殖障碍。尽管这种疾病普遍存在,但人们对这种疾病的了解仍然很少。子宫肌瘤的一个突出特征是肿瘤内的细胞产生紊乱和过量的细胞外基质(ECM)。以前,我们已经检查了ECM和产生这种过度和纤维化ECM的细胞的特征,并发现机械信号(细胞通讯和激活的方法)在肌瘤内的细胞中发生了改变。我们已经发现,构成纤维瘤的细胞对机械刺激的反应受损(降低)。此外,我们完成了一项由Wood、Stratton和Venkatesan博士领导的关于MRI引导的高频超声(HIFU)用于子宫肌瘤非手术治疗的合作临床试验。
不孕症和生殖健康差距
我们的单位继续进行不孕症和生殖健康差距的研究。阿姆斯特朗博士帮助建立了一个关于健康差异问题的特别兴趣小组和国家研究网络。 分支的研究人员帮助安排了一个新的摘要会议和研讨会,今年在美国生殖医学学会年会上讨论这种生殖健康的差异。 在过去,我们的工作人员领导了一个由NICHD主办的关于健康差距的会议。同样在过去的一年里,阿姆斯特朗博士和西格尔编辑了一期关于生殖健康差异的期刊。
BRX(也称为AKAP 13)在心脏发育,免疫功能和生殖中的作用
我们以前的研究基因BRX(AKAP 13),由我们的小组克隆,表明这个大的Rho-GEF原癌蛋白参与雌激素和糖皮质激素受体的激活。我们以前发现,BRX基因产物协调G-亚-α-s和Rho信号转导与小鼠心肌细胞发育中的一个重要转录程序,涉及肌细胞增强因子2C(MEF 2C)。AKAP 13基因(敲除)有两个缺陷拷贝的小鼠在子宫内死亡。在过去的一年中,我们已经取得了进展,在小鼠中使用Cre-Lox系统的条件基因靶向策略的发展。计划是检查有条件靶向后代的表型。此外,在接下来的一年里,我们将检查AKAP 13无效等位基因杂合小鼠的表型,以确定这些小鼠是否可能在雌激素或糖皮质激素信号传导方面存在细微异常。
英文摘要
Uterine leiomyoma
By the end of their reproductive years, over 50% of women in the United States develop uterine fibroids, making the condition the most prevalent reproductive disorder of women. Despite their prevalence, the condition remains poorly understood. One prominent feature of uterine fibroids is that cells within the tumors produce a disordered and excessive extracellular matrix (ECM). Previously, we have examined the ECM and characteristics of the cells that produce this excessive and fibrotic ECM and have found that mechanical signaling (a method of cell communication and activation) was altered in cells within a fibroid. We have found that cells that comprise a fibroid have impaired responses (decreased) to mechanical stimuli. Additionally, we completed a collaborative clinical trial led by Drs. Wood, Stratton and Venkatesan of MRI-guided high frequency ultrasound (HIFU) for the non-surgical treatment of uterine fibroids.
Infertility and reproductive health disparities
Our unit has continued to conduct studies of infertility and reproductive health disparities. Dr. Armstrong helped to established a Special Interest Group and national research network on the topic of Health Disparities. Investigators in the branch helped to arrange the a new abstract session and symposium this year at the Annual Meeting of the American Society of Reproductive Medicine on this reproductive health disparities. In the past our staff has led an NICHD-hosted conference on Health Disparities. Also in the past year, Dr. Armstrong and Segars have edited a journal issue on Reproductive Health Disparities.
Role of BRX (also known as AKAP13) in cardiac development, immune function and reproduction
Our previous studies of the gene BRX (AKAP13), cloned by our group, indicated that this large Rho-GEF protooncoprotein was involved in estrogen and glucocorticoid receptor activation. We previously found that the BRX gene product coordinates G-sub-alpha-s and Rho signaling with an essential transcription program in developing cardiomyocytes in mice, involving myocyte enhancer factor 2 C (MEF2C). Mice with two defective copies of the AKAP13 gene (knockout) died in utero. In the past year we have made progress on development of a conditional gene targeting strategy using the Cre-Lox system in mice. Plans are to examine the phenotypes of the conditionally-targeted offspring. In addition, in the coming year we will examine the phenotypes of mice heterozygous for the AKAP13 null allele to determine whether these mice may have subtle abnormalities in estrogen or glucocorticoid signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reproductive Endocrinology And Infertility Clinical Trai
-
批准号:7334114
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:7734765
-
项目类别:
-
资助金额:$201.84万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:7968644
-
项目类别:
-
资助金额:$139.49万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:8554203
-
项目类别:
-
资助金额:$79.89万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:8941580
-
项目类别:
-
资助金额:$80.51万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Trai
-
批准号:7209924
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:8149304
-
项目类别:
-
资助金额:$182.26万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical*
-
批准号:6993553
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:8351272
-
项目类别:
-
资助金额:$213.53万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
Reproductive Endocrinology And Infertility Clinical Training Program
-
批准号:7594210
-
项目类别:
-
资助金额:$64.31万
-
财政年份:--
-
负责人:James H. Segars
-
依托单位:
海外基金